Ascentage Pharma Group International (AAPG) Work In Process (2023 - 2025)

Ascentage Pharma Group International (AAPG) has reported Work In Process for 3 consecutive years, with $3.6 million the latest figure, recorded in Q4 2025.

• Quarterly Work In Process rose 839.14% year-over-year to $3.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.6 million (up 839.14% YoY) and the FY2025 annual result came in at $3.6 million, up 870.05% from the prior year.
• Work In Process grew to $3.6 million in Q4 2025 per AAPG's latest filing, from $380894.2 in the prior quarter.
• Over the last five years, Work In Process for AAPG reached as high as $3.6 million in Q4 2025 and fell as low as $380894.2 in Q4 2024.
• A 3-year average of $1.6 million and a median of $706797.9 in 2023 frame the typical range for Work In Process.
• Annual changes were most pronounced in 2024 — Work In Process plunged 46.11% — and 2025, when it soared 839.14%.
• Year by year, Work In Process stood at $706797.9 in 2023, then sank by 46.11% to $380894.2 in 2024, then surged by 839.14% to $3.6 million in 2025.
• According to Business Quant data, Work In Process over the past three periods registered $3.6 million, $380894.2, and $706797.9 for Q4 2025, Q4 2024, and Q4 2023 respectively.